Literature DB >> 25684668

The N-terminal fragment of PA subunit of the influenza A virus effectively inhibits ribonucleoprotein (RNP) activity via suppression of its RNP expression.

Yusaku Uemura1, Takahito Kashiwagi2, Koyu Hara1, Yoko Nakazono1, Nobuyuki Hamada1, Hiroshi Watanabe1.   

Abstract

The influenza RNP, which is formed from PB1, PB2, PA, NP subunits, and vRNA, is autonomously replicated and transcribed in the infected cell. The simplest method to inhibit RNP activity is to impair the formation of the RNP. Thereupon we confirmed whether the peptides/fragments mimicking one of RNP components can interfere with their formation. During the process of this inhibitory study we found interesting suppression of protein expression of the RNP components by the N-terminal fragment of PA subunit. Especially, we found two residues (D108 and K134) on the fragment that were critical for the suppression. Furthermore, we determined the combination of three amino acids (P28, M86 and E100) on the fragment that are important for the strong suppression, and identified the minimum essential region (residues from 1 to 188) of the PA subunit that allowed its suppression. Our findings indicate that the N-terminal fragment of PA subunit may become one of candidates for an effective inhibitor of influenza RNP activity.
Copyright © 2015 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Influenza A virus; Inhibitor; PA subunit; RNA polymerase; Ribonucleoprotein

Mesh:

Substances:

Year:  2015        PMID: 25684668     DOI: 10.1016/j.jiac.2014.12.007

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  1 in total

1.  A novel small-molecule inhibitor of influenza A virus acts by suppressing PA endonuclease activity of the viral polymerase.

Authors:  Shuofeng Yuan; Hin Chu; Kailash Singh; Hanjun Zhao; Ke Zhang; Richard Y T Kao; Billy K C Chow; Jie Zhou; Bo-Jian Zheng
Journal:  Sci Rep       Date:  2016-03-09       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.